Andrew Lansley backs value-based drug pricing

By Daloni Carlisle2008-09-18T09:00:00

Pharmaceutical companies should be paid according to the benefits that their drugs bring to patients, shadow health secretary Andrew Lansley has said.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters
10 expert briefings every fortnight (Premium only)
Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

to HSJ

Already a subscriber? Sign into your account here